[CLDX] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
28-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- 1.49%
YoY- 8.00%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 407 163 174 333 153 3,480 685 -29.30%
PBT -26,784 -36,004 -23,050 -20,148 -20,679 -13,373 -16,538 37.86%
Tax -912 16,564 -1,486 -874 -227 382 764 -
NP -26,784 -52,568 -21,564 -20,148 -20,452 -13,373 -16,538 37.86%
Tax Rate - - - - - - - -
Total Cost 27,191 52,731 21,738 20,481 20,605 16,853 17,223 35.54%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -6,580.84 -32,250.31 -12,393.10 -6,050.45 -13,367.32 -384.28 -2,414.31 95.01%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.57 -1.12 -0.46 -0.43 -0.45 -0.34 -0.42 22.55%
EPS Diluted -0.57 -1.12 -0.46 -0.43 -0.45 -0.34 -0.42 22.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.